Description
FeF® Strong Cetrimide Solution 40% BP Pharma with isopropyl alcohol
CAS No. 1119-97-7.
Other names: Cetrimide / Cetrimoni bromidum / Tetradecyl trimethyl ammonium bromide (TTAB)
Consists of Dodecyl trimethyl ammonium bromide (approx. 20%) and Trimethyl tetradecyl ammonium bromide (approx. 80%). Contains approx. 7.5% v/v isopropyl alcohol.
Manufactured in accordance with the cGMP Guideline ICH Q7 for Active Pharmaceutical Ingredients. Analysed according to the current British Pharmacopoeia (BP).
| Packing sizes | Item no. | Product image |
|---|---|---|
| 200 kg drum | 7800025 |  |
Documentation and services
European Drug Master File (ASMF)
GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
Certificate of Analysis (current version of pharmacopoeia)
Datasheet
Customer audits
Stability results
Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
Reach
Change Notification Statement
Pre-filled Supplier Questionnaires
Impurity profile
Description of the manufacturing process
Process flowchart
Packaging details
Quality agreements
Exposure ScenarioDownload pdf
Contact us
Corporate Headquaters
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Denmark
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact
